A Long-Term Safety Study of OZURDEX® in Clinical Practice

Study Identifier
206207-025
CT.gov Identifier
NCT01539577
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
  • Uveitis
    • Study Drug
  • dexamethasone 700 μg intravitreal implant
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Macular oedema following either BRVO or CRVO or non-infectious uveitis * Requires treatment with OZURDEX®
    Exclusion Criteria:
    * Current participation in any clinical study

    Protocol Summary

    This study is a multicenter, prospective, observational study to evaluate the long-term safety of OZURDEX® in patients with macular oedema following central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) or patients with non-infectious posterior segment uveitis in real-world clinical practice.

    Study Locations

    Location
    Status
    Location
    Paris, France
    Status
    Not applicable
    Location
    Ulm, Germany
    Status
    Not applicable
    Location
    Barcelona, Spain
    Status
    Not applicable
    Location
    Bradford, West Yorks, United Kingdom
    Status
    Not applicable